Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shenzhen Fosun Kairos Biotechnology Co., Ltd.

Clinical trials sponsored by Shenzhen Fosun Kairos Biotechnology Co., Ltd., explained in plain language.

Now part of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 600196 SSE

A subsidiary of Fosun Pharma focused on innovative biologics and biosimilars.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet recruiting 2

Automated CAR-T therapy shows promise for Tough-to-Treat lymphoma

Disease control Recruiting now

This early-phase trial is testing a CAR-T cell therapy made using an automated process for people with relapsed or refractory large B-cell lymphoma. The study will enroll 12 adults whose cancer has not responded to or returned after first-line treatment. Researchers will measure …

Phase: EARLY_PHASE1 • Sponsor: Shenzhen Fosun Kairos Biotechnology Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 13:03 UTC